Clinical trials delivered with integrity
We have been involved in delivering over 400 clinical trials across all phases which has lead to the development of our experience in diverse therapeutic areas. All clinical trials performed have allowed us to gain a broad proficiency within a variety of indications and complexity, maximizing our ability to tailor our services for each client’s specific requirements. Our success can be attributed to the highly qualified senior leadership within the company, and the dedication and expertise of our delivery teams.
Competence in oncology
We realize the need for early-stage support for companies in their endeavor for scientific advice from Competent Authorities (CA) and maneuvering new complex oncology products in the current regulatory environment. We also know that the conduct of oncology trials are challenging in many ways and that the involvement of experienced employees is crucial. Building on our strong background in conducting oncology trials, we have recently strengthened our team with renowned oncology experts, further improving our ability to drive your cancer drug through every step, from early development to market access. Whether you are a start-up, a small biopharmaceutical or a big pharma company, we have the competence and knowledge needed to manage and monitor your oncology trials in compliance with your protocols regardless of its complexity.
Collectively, our team of oncology experts have provided services in the development of drugs within the following major cancer types:
Expertise and technology for every step
With our technology and expertise in biometrics, we can support studies or registries running all over the world, allowing us to carry out a large variety of trials. Alongside our advantage as Viedoc Master Users and our clinical development support, we also support our clients in early development with planning their trials as smooth as possible. We can help you with preclinical design, CMC tasks, interactions with CA, and developing a study design to accomplish your valuable endpoints in a time, and cost-effective manner. Not only can we provide advice on regulatory processes, our early and late phase development teams can support your drug or device development from early development to marketing authorisation, including market access services.
Business area head:
Marie joins LINK Medical with a background in senior management and board membership within the CRO industry for over two decades. She holds a degree in Clinical Research and has longstanding experience in clinical development and regulatory strategy within the field of oncology, advanced therapies, biologics and gene therapies. She also serves the European Commission in reviewing the progress of Horizon 2020-funded clinical trials as an external expert and monitor